Gates Foundation Strategic Investment Fund Logo
Share this page:


									Affinivax Logo

Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine. The foundation seed funded the company to develop a low cost, broad coverage pneumococcus vaccine.

Investment Date: June 2014

News Story